Empery Asset Management, LP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Empery Asset Management, LP has filed 476 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 176-200 of 473 matching filings.

Per page
25
Current page
8
SC 13G/A

INMED PHARMACEUTICALS INC.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

HEPION PHARMACEUTICALS, INC.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

HANCOCK JAFFE LABORATORIES, INC.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

GENIUS BRANDS INTERNATIONAL, INC.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

GLOBUS MARITIME LTD.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SECOND SIGHT MEDICAL PRODUCTS, INC.

Filing date
20 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

VIVEVE MEDICAL, INC.

Filing date
19 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

APPLIED DNA SCIENCES, INC.

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

KEMPHARM, INC.

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ATOSSA THERAPEUTICS, INC.

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CASTOR MARITIME INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CELLECT BIOTECHNOLOGY LTD.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ALLENA PHARMACEUTICALS, INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ARTELO BIOSCIENCES, INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

BAUDAX BIO, INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

CHF SOLUTIONS, INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

AETHLON MEDICAL, INC.

Filing date
13 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ORBITAL ENERGY GROUP, INC.

Filing date
07 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ADOMANI, INC

Filing date
08 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

HEPION PHARMACEUTICALS, INC.

Filing date
02 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

INMED PHARMACEUTICALS INC.

Filing date
18 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

EMPERY ASSET MANAGEMENT, LP

Filing date
12 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

RING ENERGY, INC.

Filing date
02 Nov 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

ARTELO BIOSCIENCES, INC.

Filing date
15 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

HANCOCK JAFFE LABORATORIES, INC.

Filing date
15 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .